Progress in the Development of Immune-Based Therapies for Type 1 Diabetes Mellitus

By Matthias von Herrath   Rottembourg Diane   Bresson Damien  

BioDrugs, Vol. 20, Iss. 6, 2006-01 ,pp. : 341-350

Adis International

Access to resources Recommend Favorite

Therapeutic Potential of Human Amylin Analogues in Diabetes Mellitus

By Cooper G.J.S.  

BioDrugs, Vol. 10, Iss. 1, 1998-07 ,pp. : 1-9

Adis International

Access to resources Recommend Favorite

Prevention Strategies for Type 1 Diabetes Mellitus: Current Status and Future Directions

By Winter W.E.  

BioDrugs, Vol. 17, Iss. 1, 2003-01 ,pp. : 39-64

Adis International

Access to resources Recommend Favorite

Pathophysiology of Immune-Mediated (Type 1) Diabetes Mellitus: Potential for Immunotherapy

By Abel M.   Krokowski M.  

BioDrugs, Vol. 15, Iss. 5, 2001-05 ,pp. : 291-301

Adis International

Access to resources Recommend Favorite

Experience of hypoglycaemia and strategies used for its management by community-dwelling adults with diabetes mellitus: a systematic review

By Tan Pamela   Chen Hui-Chen   Taylor Beverley   Hegney Desley  

International Journal of Evidence-based Healthcare, Vol. 10, Iss. 3, 2012-09 ,pp. : 169-180

Blackwell Publishing

Access to resources Recommend Favorite